Literature DB >> 23371365

Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.

Mitsuru Shinohara1, Ronald C Petersen, Dennis W Dickson, Guojun Bu.   

Abstract

To reveal the underlying mechanisms responsible for the regional vulnerability to amyloid-β (Aβ) accumulation prior to the development of Alzheimer's disease, we studied distribution of Aβ, apolipoprotein E (apoE), synaptic markers, and other molecules involved in Aβ metabolism in multiple brain areas of non-demented individuals. Twelve brain regions including neocortical, limbic, and subcortical areas were dissected from brains of non-demented individuals and extracted according to increasing insolubility by a sequential three-step method. The levels of Aβ40, Aβ42, apoE, APP, APP-CTFβ, BACE1, presenilin-1, neprilysin, insulysin, LRP1, LDLR, synaptophysin, PSD95, GFAP, and lactate were determined by ELISAs or enzymatic assays. The regional distribution of apoE showed moderate-to-strong inverse correlation with levels of Aβ, especially insoluble Aβ40. On the other hand, the regional distributions of synaptic markers, particularly PSD95, showed moderate-to-strong positive correlation with levels of Aβ, especially soluble Aβ40. The regional correlations between Aβ and LRP1, GFAP, or lactate were mild-to-moderate. Moderate-to-strong positive regional correlations were observed between apoE and GFAP or lactate and between PSD95 and LRP1. No significant regional correlations were detected between Aβ and APP, APP-CTFβ, BACE1, or presenilin-1, those involved in Aβ production. There were no significant negative regional correlations between Aβ and two major Aβ degrading enzymes, neprilysin and insulysin. These regional correlations remained consistent regardless of the degree of Aβ accumulation. The regional vulnerability to Aβ accumulation may be due to a net balance between two competing processes: (1) synapses involved in promoting the initial Aβ accumulation and (2) astrocyte-derived apoE involved in preventing Aβ accumulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371365      PMCID: PMC3612369          DOI: 10.1007/s00401-013-1086-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  71 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

2.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

3.  FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.

Authors:  Jaehong Suh; Alvin Lyckman; Lirong Wang; Elizabeth A Eckman; Suzanne Y Guénette
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

4.  Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.

Authors:  Sophie Sokolow; Sanh H Luu; Karabi Nandy; Carol A Miller; Harry V Vinters; Wayne W Poon; Karen H Gylys
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

5.  Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

Authors:  Robert M Koffie; Tadafumi Hashimoto; Hwan-Ching Tai; Kevin R Kay; Alberto Serrano-Pozo; Daniel Joyner; Steven Hou; Katherine J Kopeikina; Matthew P Frosch; Virginia M Lee; David M Holtzman; Bradley T Hyman; Tara L Spires-Jones
Journal:  Brain       Date:  2012-05-26       Impact factor: 13.501

6.  In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain.

Authors:  K Page; R Hollister; R E Tanzi; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus.

Authors:  M C Camus; M J Chapman; P Forgez; P M Laplaud
Journal:  J Lipid Res       Date:  1983-09       Impact factor: 5.922

8.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

Authors:  Milla Koistinaho; Suizhen Lin; Xin Wu; Michail Esterman; Deanna Koger; Jeffrey Hanson; Richard Higgs; Feng Liu; Seema Malkani; Kelly R Bales; Steven M Paul
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

9.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Authors:  L Pellerin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.

Authors:  William E Klunk; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Brian J Lopresti; Scott K Ziolko; Wenzhu Bi; Jessica A Hoge; Ann D Cohen; Milos D Ikonomovic; Judith A Saxton; Beth E Snitz; Daniel A Pollen; Majaz Moonis; Carol F Lippa; Joan M Swearer; Keith A Johnson; Dorene M Rentz; Alan J Fischman; Howard J Aizenstein; Steven T DeKosky
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

View more
  31 in total

1.  Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.

Authors:  Caroline S Casey; Yuka Atagi; Yu Yamazaki; Mitsuru Shinohara; Masaya Tachibana; Yuan Fu; Guojun Bu; Takahisa Kanekiyo
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

2.  APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.

Authors:  Masaya Tachibana; Marie-Louise Holm; Chia-Chen Liu; Mitsuru Shinohara; Tomonori Aikawa; Hiroshi Oue; Yu Yamazaki; Yuka A Martens; Melissa E Murray; Patrick M Sullivan; Kathrin Weyer; Simon Glerup; Dennis W Dickson; Guojun Bu; Takahisa Kanekiyo
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

Review 3.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

4.  Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.

Authors:  Mitsuru Shinohara; Melissa E Murray; Ryan D Frank; Motoko Shinohara; Michael DeTure; Yu Yamazaki; Masaya Tachibana; Yuka Atagi; Mary D Davis; Chia-Chen Liu; Na Zhao; Meghan M Painter; Ronald C Petersen; John D Fryer; Julia E Crook; Dennis W Dickson; Guojun Bu; Takahisa Kanekiyo
Journal:  Acta Neuropathol       Date:  2016-05-14       Impact factor: 17.088

5.  Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1.

Authors:  Masaya Tachibana; Mitsuru Shinohara; Yu Yamazaki; Chia-Chen Liu; Justin Rogers; Guojun Bu; Takahisa Kanekiyo
Journal:  Exp Neurol       Date:  2015-12-11       Impact factor: 5.330

6.  Subacute ibuprofen treatment rescues the synaptic and cognitive deficits in advanced-aged mice.

Authors:  Justin T Rogers; Chia-Chen Liu; Na Zhao; Jian Wang; Travis Putzke; Longyu Yang; Mitsuru Shinohara; John D Fryer; Takahisa Kanekiyo; Guojun Bu
Journal:  Neurobiol Aging       Date:  2017-02-09       Impact factor: 4.673

Review 7.  Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.

Authors:  Mitsuru Shinohara; Masaya Tachibana; Takahisa Kanekiyo; Guojun Bu
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

Review 8.  ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Authors:  Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

9.  C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins.

Authors:  Yong-Jie Zhang; Tania F Gendron; Jonathan C Grima; Hiroki Sasaguri; Karen Jansen-West; Ya-Fei Xu; Rebecca B Katzman; Jennifer Gass; Melissa E Murray; Mitsuru Shinohara; Wen-Lang Lin; Aliesha Garrett; Jeannette N Stankowski; Lillian Daughrity; Jimei Tong; Emilie A Perkerson; Mei Yue; Jeannie Chew; Monica Castanedes-Casey; Aishe Kurti; Zizhao S Wang; Amanda M Liesinger; Jeremy D Baker; Jie Jiang; Clotilde Lagier-Tourenne; Dieter Edbauer; Don W Cleveland; Rosa Rademakers; Kevin B Boylan; Guojun Bu; Christopher D Link; Chad A Dickey; Jeffrey D Rothstein; Dennis W Dickson; John D Fryer; Leonard Petrucelli
Journal:  Nat Neurosci       Date:  2016-03-21       Impact factor: 24.884

10.  Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.

Authors:  Corbin Bachmeier; Ben Shackleton; Joseph Ojo; Daniel Paris; Michael Mullan; Fiona Crawford
Journal:  Neuromolecular Med       Date:  2014-12       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.